ReviewJournal of cancer research and clinical oncology2023

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations.

Ruoxue Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.